Moderna Inc (NAS:MRNA)
$ 132.68 3.58 (2.77%) Market Cap: 50.85 Bil Enterprise Value: 42.17 Bil PE Ratio: 0 PB Ratio: 3.86 GF Score: 68/100

Moderna Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2020 / 01:00PM GMT
Release Date Price: $82.44 (+8.40%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

And we're live. Welcome, everyone, to Day 3 of the Crédit Suisse virtual health care conference. My name is Evan Seigerman. I'm the senior biopharma analyst here at Crédit Suisse. And for Day 3, it's my pleasure to have Moderna. And from Moderna, we have CEO, Stéphane Bancel; Dave Meline, CFO, I almost had to do a double take because last year I had him with his former employer, Amgen; and Lavina from the IR team. And it's my pleasure to have all 3 of you on. I know, Stéphane, you wanted to have a few slides, and then we're going to jump right into Q&A.

StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

Great. Well, Evan, thank you so much for having us, and I hope everybody is doing well.

I wont go and read you the forward-looking statement. You can find them in all our websites, but they're important, of course.

So let me give you a couple of quick updates. Of course, I'm sure we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot